About us

Next Biomed Therapies Oy is a privately owned company established in 2015 to develop SH3 scaffold protein technologies for use as components of bispecific antibody therapeutics and other innovative biopharmaceuticals.

Click here to read more of this
rating for creditworthiness
and reliability